Download Files:
Products Details
Product Description
– RdRP-IN-7 is a RNA-dependent RNA polymerase (RdRp) inhibitor that shows the inhibition of SARS-CoV-2 infection with an IC50 of 8.2 μM, an IC90 of 14.1 μM and an CC90 of 79.1 μM. RdRP-IN-7 can be used for antiviral research[1].
Web ID
– HY-154990
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C26H45N7O3Si2
References
– [1]Savio Cardoza, et.al.Multistep Synthesis of Analogues of Remdesivir: Incorporating Heterocycles at the C-1′Position. The Journal of Organic Chemistry 2023 88 (13), 9105-9122
Molecular Weight
– 559.85
SMILES
– OC[C@@H]1[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C(C)(C)C)(C)C)[C@](C2=CNN=N2)(C3=CC=C4C(N)=NC=NN34)C1
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– SARS-CoV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
